These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 14655759)
1. TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways. Song JH; Song DK; Pyrzynska B; Petruk KC; Van Meir EG; Hao C Brain Pathol; 2003 Oct; 13(4):539-53. PubMed ID: 14655759 [TBL] [Abstract][Full Text] [Related]
2. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Hao C; Beguinot F; Condorelli G; Trencia A; Van Meir EG; Yong VW; Parney IF; Roa WH; Petruk KC Cancer Res; 2001 Feb; 61(3):1162-70. PubMed ID: 11221847 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Zhang L; Fang B Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937 [TBL] [Abstract][Full Text] [Related]
4. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837 [TBL] [Abstract][Full Text] [Related]
5. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis. Kim JH; Ajaz M; Lokshin A; Lee YJ Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells. Song JH; Song DK; Herlyn M; Petruk KC; Hao C Clin Cancer Res; 2003 Sep; 9(11):4255-66. PubMed ID: 14519653 [TBL] [Abstract][Full Text] [Related]
7. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Song JH; Bellail A; Tse MC; Yong VW; Hao C J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480 [TBL] [Abstract][Full Text] [Related]
8. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release. Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. Xiao C; Yang BF; Asadi N; Beguinot F; Hao C J Biol Chem; 2002 Jul; 277(28):25020-5. PubMed ID: 11976344 [TBL] [Abstract][Full Text] [Related]
11. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells. Uno K; Inukai T; Kayagaki N; Goi K; Sato H; Nemoto A; Takahashi K; Kagami K; Yamaguchi N; Yagita H; Okumura K; Koyama-Okazaki T; Suzuki T; Sugita K; Nakazawa S Blood; 2003 May; 101(9):3658-67. PubMed ID: 12506034 [TBL] [Abstract][Full Text] [Related]
12. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Mitsiades N; Poulaki V; Mitsiades C; Tsokos M Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151 [TBL] [Abstract][Full Text] [Related]
13. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway. Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965 [TBL] [Abstract][Full Text] [Related]
14. Chemical sensitization and regulation of TRAIL-induced apoptosis in a panel of B-lymphocytic leukaemia cell lines. Kang J; Kisenge RR; Toyoda H; Tanaka S; Bu J; Azuma E; Komada Y Br J Haematol; 2003 Dec; 123(5):921-32. PubMed ID: 14632785 [TBL] [Abstract][Full Text] [Related]
15. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Suliman A; Lam A; Datta R; Srivastava RK Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196 [TBL] [Abstract][Full Text] [Related]
16. Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells. Mitsiades N; Mitsiades CS; Poulaki V; Anderson KC; Treon SP Blood; 2002 Mar; 99(6):2162-71. PubMed ID: 11877293 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage. Ramp U; Caliskan E; Mahotka C; Krieg A; Heikaus S; Gabbert HE; Gerharz CD Br J Cancer; 2003 Jun; 88(11):1800-7. PubMed ID: 12771998 [TBL] [Abstract][Full Text] [Related]
18. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R; Bedi A Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014 [TBL] [Abstract][Full Text] [Related]
19. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation. Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934 [TBL] [Abstract][Full Text] [Related]
20. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy. Wang S; El-Deiry WS Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]